Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Oruka Therapeutics, Inc. (ORKA) had Weighted-Average Shares Outstanding (Diluted) of 42.10M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-24.57M |
|
-- |
|
-- |
|
$28.43M |
|
$-28.43M |
|
$3.85M |
|
$-24.57M |
|
$-24.57M |
|
$-24.57M |
|
$-24.57M |
|
$-24.57M |
|
$-24.57M |
|
$-28.43M |
|
$-29.91M |
|
42.10M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
42.10M |
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$332.01M |
|
$0.17M |
|
$25.41M |
|
$357.42M |
|
$12.11M |
|
-- |
|
$1.67M |
|
$13.78M |
|
$340.71M |
|
$343.64M |
|
$343.64M |
|
37.45M |
|
| Cash Flow Statement Financials | |
$-44.01M |
|
$47.73M |
|
$0.11M |
|
$61.58M |
|
$65.40M |
|
$3.82M |
|
$9.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.21% |
|
-7.15% |
|
-6.88% |
|
-7.15% |
|
$9.18 |
|
$-1.05 |
|
$-1.05 |
|